Facile synthesis of manganese silicate nanoparticles for pH/GSH-responsive T 1 -weighted magnetic resonance imaging
Source abstract
Abstract
Contrast agents (CAs) play an important role in enhancing the magnetic resonance imaging (MRI) performance for accurate tumor diagnosis, which, however, may give rise to unexceptional issues such as in vivo accumulation and bio-toxicity. Here we report on manganese silicate nanoparticles (denoted as MnSNs) as highly biocompatible and pH/GSH-responsive T1-weighted MRI CAs. The MnSNs were synthesized via a facile, cost-effective and environmentally friendly route based on one-step rapid precipitation between the Mn2+ cation and the SiO3 2- anion in aqueous solution at room temperature without any other additives, and showed excellent dispersion stability in water or PBS for weeks without any surface modification at ambient temperature. The MnSNs present an efficient pH/GSH-responsive T1-MRI feature based on the rapid changes in the relaxation rate in a mildly acidic/reducing environment both in vitro and in vivo, and furthermore, MnSNs showed negligible cellular cytotoxicity in vitro, no distinct tissue toxicity in vivo and fast clearance from the body organs and tissues in 24-72 h. Thus, the MnSNs are able to serve as a novel class of highly promising T1-MRI CAs for clinical cancer diagnosis.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Lanthanide and Transition Metal Complexes · Nanoparticle-Based Drug Delivery · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory for Ultrafine Materials of Ministry of Education
School of Materials Science and Engineering
East China University of Science and Technology
Shanghai 200237
China
State Key Laboratory of Bioreactor Engineering
Department of Radiology
Shanghai Cancer Center
Fudan University
Shanghai 200032
References (45)
Show source-provided references
1. S. A. Huettel , A. W.Song and G.McCarthy, Functional magnetic resonance imaging, Sinauer Associates, Sunderland, 2004
2. Fox · Nat. Rev. Neurosci. · 2007 · 8 · 70010.1038/nrn2201 ↗
3. R. W. Brown , Y.-C. N.Cheng, E. M.Haacke, M. R.Thompson and R.Venkatesan, Magnetic resonance imaging: physical principles and sequence design, John Wiley & Sons, 201410.1002/9781118633953 ↗
4. Na · Adv. Mater. · 2009 · 21 · 213310.1002/adma.200802366 ↗
5. Viswanathan · Chem. Rev. · 2010 · 110 · 296010.1021/cr900284a ↗
6. Davies · Chem. Commun. · 2013 · 49 · 970410.1039/c3cc44268c ↗
7. Lee · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2014 · 6 · 19610.1002/wics.1311 ↗
8. Caravan · Chem. Rev. · 1999 · 99 · 229310.1021/cr980440x ↗
9. Caravan · Chem. Soc. Rev. · 2006 · 35 · 51210.1039/b510982p ↗
10. Aime · J. Am. Chem. Soc. · 2007 · 129 · 243010.1021/ja0677867 ↗
11. Penfield · Nat. Clin. Pract. Nephrol. · 2007 · 3 · 65410.1038/ncpneph0660 ↗
12. Idée · Radiol. Clin. North Am. · 2009 · 47 · 85510.1016/j.rcl.2009.06.006 ↗
13. Perez-Rodriguez · Radiology · 2009 · 250 · 37110.1148/radiol.2502080498 ↗
14. Sieber · J. Magn. Reson. Imaging · 2009 · 30 · 126810.1002/jmri.21971 ↗
15. Aschner · Brain Res. Bull. · 1990 · 24 · 85710.1016/0361-9230(90)90152-P ↗
16. Aschner · Mol. Aspects Med. · 2005 · 26 · 35310.1016/j.mam.2005.07.003 ↗
17. Pittman · New Phytol. · 2005 · 167 · 73310.1111/j.1469-8137.2005.01453.x ↗
18. Roth · Biol. Res. · 2006 · 39 · 4510.4067/S0716-97602006000100006 ↗
19. Koretsky · NMR Biomed. · 2004 · 17 · 52710.1002/nbm.940 ↗
20. Silva · NMR Biomed. · 2004 · 17 · 53210.1002/nbm.945 ↗
21. Zhen · Theranostics · 2012 · 2 · 4510.7150/thno.3448 ↗
22. Shin · Angew. Chem., Int. Ed. · 2009 · 48 · 32110.1002/anie.200802323 ↗
23. Huang · Chem. Commun. · 2010 · 46 · 668410.1039/c0cc01041c ↗
24. Yang · Adv. Funct. Mater. · 2010 · 20 · 173310.1002/adfm.200902445 ↗
25. Kim · J. Am. Chem. Soc. · 2011 · 133 · 295510.1021/ja1084095 ↗
26. Maeda · J. Controlled Release · 2000 · 65 · 27110.1016/S0168-3659(99)00248-5 ↗
27. Acharya · Adv. Drug Delivery Rev. · 2011 · 63 · 17010.1016/j.addr.2010.10.008 ↗
28. Fang · Adv. Drug Delivery Rev. · 2011 · 63 · 13610.1016/j.addr.2010.04.009 ↗
29. Yu · ACS Nano · 2015 · 9 · 665510.1021/acsnano.5b01320 ↗
30. Argilés · Mol. Cell. Biochem. · 1988 · 81 · 310.1007/BF00225648 ↗
31. Z. M. Bhujwalla , D.Artemov, E.Aboagye, E.Ackerstaff, R. J.Gillies, K.Natarajan and M.Solaiyappan, The physiological environment in cancer vascularization, invasion and metastasis, Novartis Found Symp: Chichester, John Wiley, New York, 2001
32. Urano · Nat. Med. · 2009 · 15 · 10410.1038/nm.1854 ↗
33. Perry · Cancer · 1993 · 72 · 78310.1002/1097-0142(19930801)72:3<783::AID-CNCR2820720325>3.0.CO;2-U ↗
34. Kuppusamy · Cancer Res. · 2002 · 62 · 307
35. Russo · Cancer Res. · 1986 · 46 · 2845
36. Chen · Nanoscale · 2015 · 7 · 1576310.1039/C5NR04612B ↗
37. Chen · Biomaterials · 2012 · 33 · 238810.1016/j.biomaterials.2011.11.086 ↗
38. Chen · Biomaterials · 2012 · 33 · 712610.1016/j.biomaterials.2012.06.059 ↗
39. Kim · Biomaterials · 2013 · 34 · 894110.1016/j.biomaterials.2013.08.009 ↗
40. Chen · Adv. Funct. Mater. · 2014 · 24 · 438610.1002/adfm.201400221 ↗
41. Chen · Adv. Mater. · 2014 · 26 · 701910.1002/adma.201402572 ↗
42. He · Microporous Mesoporous Mater. · 2010 · 131 · 31410.1016/j.micromeso.2010.01.009 ↗
43. Singh · Proc. Natl. Acad. Sci. U. S. A. · 2006 · 103 · 335710.1073/pnas.0509009103 ↗
44. Longmire · Nanomedicine · 2008 · 3 · 70310.2217/17435889.3.5.703 ↗
45. He · Small · 2011 · 7 · 27110.1002/smll.201001459 ↗